400
Participants
Start Date
January 31, 2015
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
HPDCs-T immune therapy
HPDCs-T immune therapy:one time every 2 weeks during 12 weeks to 36 weeks, IV (in the vein), about 2\*105-1\*106 cells per time,total 12 times;
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
The second people's hospital of yunnan province, Kunming
Ruijin Hospital
OTHER
Second People's Hospital of Yunnan Province
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER